Abstract
Nosocomial transmission of respiratory syncytial virus (RSV) is a serious, preventable cause of RSV infection. Passive RSV prophylaxis became available in 1996. We compared the RSV nosocomial infection rate in our neonatal intensive care unit before and after RSV prophylaxis, using nosocomial rotavirus infections as a comparator. There were no significant differences between nosocomial RSV infection rates before and after institution of prophylaxis.
Original language | English (US) |
---|---|
Pages (from-to) | 842-844 |
Number of pages | 3 |
Journal | Pediatric Infectious Disease Journal |
Volume | 28 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2009 |
Keywords
- Neonatal intensive care unit
- Palivizumab
- Prophylaxis
- Respiratory syncytial virus
- Respiratory syncytial virus-immune globulin
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)
- Infectious Diseases